New cancer clinical trial: Safety and Pharmacokinetics of ODM-208 in Patients With Metastatic Castration-resistant Prostate Cancer

Published on: February 16, 2018 at 12:00PM
Condition:   Prostate Cancer Metastatic
Intervention:   Drug: ODM-208
Sponsor:   Orion Corporation, Orion Pharma
Not yet recruiting
http://ift.tt/2Gu6Ozo